Drugs / mouse TYRP2 DNA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00680589 | Jul 2006 → Mar 2011 | melanoma | Memorial Sloan Kettering Cancer Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mouse TYRP2 DNA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00680589 ↗ |
| Modality | Vaccine | “The DNA vaccine is then made from bacteria that is inactive.” NCT00680589 ↗ |
| Route | Intramuscular | “delivered intramuscularly” NCT00680589 ↗ |